The report "Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care)- Global Forecast to 2031" is projected to grow from USD 0.35 billion in 2025 and to reach USD 0.35 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 35.2% during the...